Pilot Study of a Raltegravir Based NRTI Sparing Regimen

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2012 by Yale University.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Bristol-Myers Squibb
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Michael J Kozal, Yale University
ClinicalTrials.gov Identifier:
NCT00814879
First received: December 18, 2008
Last updated: February 28, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2013
  Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)